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The widespread exposure of the UK population to bovine spongiform encephalopathy prions, and
the potential consequences for public health, led to a renewed interest in kuru, the principal example
of epidemic human prion disease. Kuru research in Papua New Guinea was expanded to study the
range of incubation periods possible in human prion infection, to investigate maternal and other
possible natural routes of transmission, to characterize genetic susceptibility and resistance factors
and to gain insights into the peripheral pathogenesis of orally acquired prion disease in humans.
Although now essentially over, the kuru epidemic continues to provide important lessons.
Keywords: kuru; prion; public health
It was in the early 1990s, when I was a junior doctor
training in neurology and investigating genetic suscep-
tibility to CJD and other prion diseases, that kuru
became of increasing interest to me. The ﬁrst
mutations in the prion protein gene had been identiﬁed
in 1988–1989 and the evidence suggested that these
were causal for familial forms of spongiform encepha-
lopathy and could be used in their deﬁnitive diagnosis
(Owen et al. 1989; Collinge et al. 1989, 1990; Hsiao
et al. 1989). This was somewhat controversial at the
time but, if correct, offered a powerful direct route into
understanding the pathogenesis of a neurodegenerative
disorder. Furthermore, it had been known for some
time that brain tissue from patients dying of these
familial diseases could transmit the disease to labora-
tory animals by inoculation. This strongly suggested
that some form of the so-called ‘protein-only’
hypothesis (Grifﬁth 1967; Prusiner 1982) was likely
to be correct, with major biological implications, not
least owing to the existence of multiple ‘strains’ of the
infectious agent known from long-standing work with
sheep scrapie. Kuru was of course the ﬁrst of the
human prion diseases shown to be transmissible
(Gajdusek et al. 1966), and offundamental importance
in the development of the ﬁeld, but was largely thought
to be of historical interest by this time.
However, against the background of these genetic
advances and growing interest in the unique biology of
these rare forms of human neurological disease was an
emerging crisis that would unfold to worldwide
prominence. The arrival of bovine spongiform ence-
phalopathy (BSE; Wells et al. 1987) led a new impetus
to understanding diseases long known to be transmis-
sible, at least experimentally, between, aswellaswithin,
mammalian species. BSE rapidly developed into a
major epidemic among UK cattle, estimated to have
infected more than 2 million animals (Ghani et al.
2002), and was being increasingly recognized in other
countries. The dominant view at that time was that
BSE was simply scrapie in cattle. Cattle feed included
meat and bone meal prepared from the rendered
carcases of ruminants, which would have included
scrapie-infected sheep. Since it was known that sheep
scrapie had been around for centuries as a relatively
common disease without apparent consequences for
human health (epidemiological studies had shown no
link between CJD and scrapie prevalence (Brown et al.
1987)), it was argued that BSE would also be no threat
to human health. This view was increasingly challenged
by the arrival and recognition of novel prion diseases in
captive exotic ungulates and then, notably, in domestic
cats ca 1990 (Wyatt et al. 1991). Cats had not hitherto
been affected by these diseases. Indeed this was
sufﬁciently high proﬁle for the leading pet food
manufacturer to rapidly withdraw an advertising
campaign for their cat food bearing the slogan ‘what
bowls a cat over?’ It became apparent that BSE,
whether or not it had originated from some form of
sheep scrapie, had a different host range and crossed
between some species relatively easily by the oral route.
Whether or not the host range of this novel infectious
prion would involve humans could not be predicted but
was clearly entirely possible. Furthermore, the popu-
lation exposure to BSE prions was large, particularly
before the ban on dietary use of speciﬁed offal (notably
the brain and spinal cord) was introduced and effectively
enforced. Bovine-derived materials had also been widely
usedinthemanufactureofmedicines,vaccinesandmany
consumer products, including cosmetics. The key issue
was the effectiveness of the so-called ‘species barrier’,
known to limit cross-species transmission, which would
determinethesizeofanycorrespondinghumanepidemic
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not be predicted, and in laboratory animals are
experimentallydetermined.Clearly,thiswasnotpossible
in humans, and the effectiveness of the BSE-to-human
barrier was therefore quite unknown. The molecular
basis of such barriers was then beginning to be studied
experimentally using transgenic mice (Prusiner et al.
1990) and we had set up long-term comparative
transmission studies in ‘humanized’ transgenic mice to
investigate the ability of BSE prions to propagate using
human prion protein to address this key issue (Collinge
et al.1 9 9 5 ).
Kuru, of course, provided the principal experience
of an epidemic human prion disease, and one that had
apparently been transmitted predominantly by the oral
route. The prevailing assumption at the time was that
kuru had effectively disappeared following a long
decline in the epidemic after the interruption of its
route of transmission: consumption of the deceased by
their relatives at mortuary feasts. However, I had heard
that, in fact, cases were still occurring, suggesting
remarkable incubation periods. While the disease had
been very extensively investigated in a series of seminal
studies outlined elsewhere in this issue, it seemed that
further study might yield speciﬁc information of
relevance to these growing public health concerns.
With this evolving background, I wrote to Michael
Alpers, then Director of the Papua New Guinea
Institute of Medical Research (PNGIMR), in Goroka
in 1992. Although I was by then very familiar with his
published work on kuru, I had never met Michael.
I explained my interest in kuru and asked whether
indeed cases were still occurring and also whether it
might be feasible to conduct an autopsy to collect
tissues for the study using the newly emerging
techniques. Michael responded by return of mail and
said he had read my work, he would be happy to
collaborate and that perhaps six to eight cases of kuru
were still occurring annually. He suggested sending
someone out to work in the ﬁeld for six months initially.
When I subsequently discussed what sort of person I
should send, he replied ‘up to you, but do not send
someone wearing a pith helmet’. ‘Oh, and you have to
come too’. With this insightful advice, a long-term
collaboration and friendship started.
Funding was of course then required. I was
fortunate at that time to be funded as a Fellow of the
Wellcome Trust (then directed by Bridget Ogilvie, who
kindly spoke at the kuru symposium). The programme
manager responsible for my research funding was
David Gordon. The Wellcome Trust was to be
enormously supportive to me personally as well as
professionally during the subsequent BSE crisis. I went
into the Trust ofﬁces on the Euston Road in London to
see David to ask whether they might fund a small
project on kuru. I discussed my rationale and outline
plans and received an enthusiastic and characteri-
stically straightforward reply. I was asked to draft a
short application as a supplement to my fellowship to
fund the project but was told ‘do not spend a lot of time
on this, a couple of paragraphs will do, and just do
some back of the envelope costings’. A few weeks later,
the project was funded although at a level higher than
that I had asked for; the Trust felt I had not asked for as
much as I would need.
The next step proved more difﬁcult and much more
time consuming: ﬁnding the right person to send to
Goroka. My ﬁrst thoughts were to recruit a young
clinician, preferably a pathologist. It became apparent
that the rigidity of postgraduate medical training made
this problematic. A distinguished pathologist colleague
contacted me and suggested another approach, recruit-
ing a nurse with extensive experience working in
remote environments who could be trained to take on
other responsibilities. My colleague had someone in
mind and shortly thereafter introduced me to Jerome
Whitﬁeld. Jerome had an impressive, if unorthodox,
curriculum vitae having worked as a paramedic in the
army and with wide experience as a medical aid worker
in developing countries. We talked for an hour or so in
myofﬁce at St Mary’s Hospital and it was apparent that
Jerome was ideal and someone I felt would get on with
everyone in what was undoubtedly going to be a
challenging and wide-ranging role. He was also, as I
was soon to learn to my cost in hopeless attempts to
keep up with him on ﬁeldwork, extremely physically ﬁt,
even, as I came to discover, by Fore standards. He
agreed to go out to Papua New Guinea (PNG) for six
months. Of course Michael knew well, and I soon
learned, that the scientiﬁc objectives we had discussed
would take far longer. Jerome would often say to
visiting colleagues over a beer when we met in Goroka:
‘John told me I would be here for six months, and here
I am a decade later’. Fortunately, the Wellcome Trust
continued to generously support the project and
Jerome was beginning to take to PNG.
In 1996 of course, the prion ﬁeld exploded. During
1995, we had been involved in the investigation of three
remarkably young patients (two teenagers and a
woman in her 20s) who were neuropathologically
diagnosed as CJD. Sporadic CJD was a disease of late
adult life and exceedingly rare below the age of 40.
There was no history to suggest iatrogenic exposure to
human prions and we had sequenced the prion protein
gene in all three and found no causal mutations
(Bateman et al. 1995; Britton et al. 1995; Tabrizi et al.
1996). Each case generated massive media interest and
made front page headlines in the UK. Print and
broadcast journalists asked on each occasion ‘is this
BSE?’ I answered, honestly, that I did not know and
that you could not reach conclusions on individual
cases but the occurrence of further similar cases would
be very concerning. Following the third case, I was
asked how many would have to be seen before it could
be concluded this was BSE. I did not want to be drawn
on that, but privately, and instinctively rather than on
any formal statistical analysis, felt a fourth such
extraordinary case in the UK following soon after
would be enough at least to begin working on the
assumption this was BSE-related with respect to public
health considerations. We set up transmission studies
into humanized transgenic mice of two of the cases in
November 2005, so that these could be compared with
our growing body of data on the transmission
characteristics of the various forms of ‘classical’ CJD
(Hill et al. 1997). Such experiments, which may not in
any case have provided clear answers, were very time
3690 J. Collinge Review. Lessons of kuru research
Phil. Trans. R. Soc. B (2008)consuming and likely to take 2 years. The key issue
would be to determine the prion strain type causing
these cases and whether it was similar to that causing
BSE in cattle.
In December 1995, I was invited by the Chief
Medical Ofﬁcer to join the UK Government’s Spongi-
form Encephalopathy Advisory Committee (SEAC)
and attended its next meeting in January 1996. At this
meeting,I heard that twofurther extremely young cases
had been identiﬁed by the National CJD Surveillance
Unit, making a total ofﬁve. My own view then was that
these cases were likely to be related to BSE exposure
and we must work on this basis and immediately
review measures in place to protect public health. This
was not a view shared by all on the committee. By
March, a total of 10 cases had been documented by the
Surveillance Unit, all having a new pattern of
neuropathology, which was presented to the committee
by Professor Ironside, and SEAC concluded a new
form of CJD had emerged in the UK probably related
to BSE exposure, leading to the Government announ-
cement in the House of Commons on March 20. This
became known as ‘new variant’ CJD (Will et al. 1996).
We considerably intensiﬁed ongoing work in my
research group attempting to distinguish prion strains
using rapid molecular methods and were able to
distinguish the disease-associated prion protein
(PrP
Sc) type in new variant CJD from classical CJD
types and showed it had a molecular signature closely
similar to that causing BSE in cattle (Collinge et al.
1996). This experimental evidence that new variant
CJD was indeed caused by a BSE-like strain was
further supported by biological strain typing experi-
ments in transgenic and conventional mice the
following year (Bruce et al. 1997; Hill et al. 1997).
I was asked by the Medical Research Council
(MRC) to expand my research group and develop an
MRC Unit to work on prion disease, both to tackle the
public health issues posed by vCJD and to study the
fundamental molecular biology of prions and its wider
implications. The MRC Prion Unit was formed in
1998 and led to a widening of our research on kuru,
interest in which had redoubled since the arrival of new
variant CJD. In particular, kuru provided a unique
opportunity to study the range of incubation periods
possible in human prion infection, investigate maternal
and other possible natural routes of transmission,
characterize genetic susceptibility and resistance
factors and gain insights into the peripheral patho-
genesis of orally acquired prion disease in humans.
The scientiﬁc objectives of our kuru research
programme were as follows: to identify and study all
remaining kuru patients and document the maximum
incubation periods; to provide further data for accurate
epidemiological modelling of the kuru epidemic to
estimate key epidemic parameters; to document
mortuary feast practices and traditional beliefs of the
aetiology of kuru by interview of surviving participants
and other members of the Fore community; to study
the clinical features of current kuru patients and
compare clinical and other diagnostic features with
other human prion diseases, notably iatrogenic and
variant CJD; to investigate any evidence of maternal or
other routes of kuru transmission; to identify genetic
susceptibility factors to kuru by study of recent patients
and archived samples, long-term survivors of multiple
feast exposures and the normal Fore and adjacent
(exposed and unexposed) populations; to study the
peripheral pathogenesis of kuru and tissue distribution
of infectivity; and investigate the possibility of sub-
clinical prion infection by analysis of autopsy tissues
from patients and elderly exposed, but clinically
unaffected, individuals.
Jerome led the re-establishment of research infra-
structure and active kuru surveillance under Michael’s
guidance. A ﬁeld base was established in Waisa in the
South Fore and the PNGIMR house in the village
refurbished, modernized and equipped to support the
research programme (ﬁgure 1). The house, which had
been rarely used, required considerable work to make it
liveable and Jerome then established a garage, and fuel
and equipment stores. Solar power was installed for
lighting and the recharging of batteries. A small
adjacent laboratory, for the fractionation and freezing
of blood samples, was built and fully equipped with
lighting, water supply, hand-powered centrifuge and a
K408C freezer. A team of local ﬁeldworkers and kuru
reporterswas augmented, equipped and employed long
term via the PNGIMR to assist with the project.
A specially adapted Land Rover vehicle to support the
project was shipped from the UK and a helicopter
landing area was established by Jerome in the village for
use of charter helicopters when road conditions were
hazardous or impractical. The PNGIMR kindly
provided an ofﬁce base and administrative support for
the project in Goroka.
The ﬁeldwork has involved Jerome and his team
walking thousands of miles in arduous terrain in poor
weather conditions at high altitude in the Eastern
Highlands Province (the Fore area is largely around
7000 feet above sea level; ﬁgure 2). Poor (to appalling
and impassable in the wet season) road conditions
hampered work (ﬁgure 3). The roads have signiﬁcantly
deteriorated over recent years. It takes 36 hours to
cover 40 km in the wet season with heavy vehicle rescue
equipment and a six-man team. Local politics often
caused long delays to ﬁeldwork. Local security issues
intermittently affected our ability to travel to and from
Figure 1. Field research house and laboratory in the village of
Waisa, South Fore.
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his team documented all cases of kuru since 1996.
Working in PNG involves particular challenges and
responsibilities with logistical, political and ethical
issues to manage. Of course, the project was built
entirely on the earlier work on kuru by Michael and the
PNGIMR. Formal ethical approval was obtained from
the PNG Medical Research Advisory Committee as
well as from our ethics committees in London, but
critically important from both the ethical and oper-
ational aspects was the full participation in the project
of the communities involved. This involved both the
Fore communities and neighbouring kuru-affected and
unaffected linguistic groups from which we collected
blood samples for comparative genetic studies. This
was established and maintained through discussions
with village leaders, communities, families and indi-
viduals (ﬁgure 4). The project adopted the usual
procedures of research projects such as this one in
PNG, where it is expected that in the course of studying
human disease in the community some form of
development, human, social or structural, will be
achieved. We adopted the principles and standard
practice of the PNGIMR in the conduct of the project
in the ﬁeld. It would be wrong to build up a strong
participatory relationship with the communities and
when the project was over leave nothing behind.
Obviously, medical and nursing staff from the Unit
also provided help, working where possible with local
clinic facilities, to provide medical care. Kuru was
thankfully by this time a rare cause of disease in these
communities, who however faced major challenges
with conventional infectious diseases (e.g. pneumo-
coccal pneumonia, typhoid and malaria) and trauma,
which we do our best to assist with.
We aimed to establish good relationships with local
communities, based on mutual trust and respect of
different beliefs as to the aetiology of kuru. Ongoing
and regular discussions with the local community and
its leaders are a vital part of the project. We have held
medical clinics in remote areas and provided emer-
gency medical treatment when required (ﬁgure 5).
Figure 3. Typical recent conditions on Okapa road.
Figure 2. Jerome Whitﬁeld on patrol.
Figure 4. Village meeting in Waisa to discuss MRC/PNGIMR
kuru research project.
Figure 5. Jerome Whitﬁeld at a local clinic.
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suffer from a wide range of infectious diseases. We have
assisted the local Ivingoi Health Centre with medicine,
diagnostics and casualty evacuation by car and
helicopter. We have carried out complete treatment of
malaria in villages affected by seasonal malaria out-
breaks, and project personnel were trained for house
spraying of insecticides in malaria-affected areas;
spraying starts in the wet season with equipment
and supervision provided by the PNG Provincial
Malaria Unit.
We have assisted in the establishment of pre-schools
in several villages and in the transport of building and
school materials. The schools are run on a local basis
with support from the Government and helped by
funding from a UK-based charity and have proved to
be sustainable (ﬁgures 6 and 7). With help from the
British High Commission in Port Moresby, we
established safe water supplies in a number of villages.
My ﬁrst visit to the Fore was relatively brief, with
only a few days in Waisa, but made a lasting impression
on me. The terrain was staggeringly beautiful but made
for challenging walking between villages. The warmth
of the welcome, and generosity and openness of all I
met was moving and inspiring. I presented a specially
commissioned trophy to be used in the local rugby
competition and was in turn presented with a
formidable Fore bow with a range of arrows and
instruction in their use. I have been fortunate in having
been able to make annual trips since to see suspected
patients when possible and to regularly attend the
annual PNG Medical Symposium. Indeed these visits
to the Fore and PNG more generally have become an
important, highly educational and intensely rewarding
part of my professional life. It also has led to ever-
increasing respect and admiration for Michael Alpers
(ﬁgure 8), with whom it has been nothing other than a
privilege for me to collaborate. The respect and
affection with which he is held by the Fore and more
widely in PNG is profound, and appropriately so.
Soon after the events of 1996 in the UK, the BBC
made two programmes on BSE and variant CJD as part
of the science documentary series ‘Horizon’, in which
the Unit featured heavily. We were able to use extracts
from these programmes as teaching material and
showed video at Ivingoi mission station where a
generator and video player facilities existed. There
was great interest in vCJD and the obvious similarities
to kuru. Indeed some began to refer to vCJD as
‘English kuru’. On one occasion while Jerome and I
attempted to explain the project to the community in a
village in the South Fore, an elderly gentleman leaning
quietly against a house interjected saying words to the
effect of ‘You know, maybe kuru is not caused by
sorcery after all if the white man gets it since we know
they do not do sorcery’. A very thoughtful comment
but with unfortunately a misplaced respect for the
rationality of Europeans. I often found it worth asking
those back in the UK, who express surprise that the
Fore considered kuru to be caused by sorcery, whether
they read horoscopes. Of course, magical or religious
thinking about disease causation and cure permeates all
human cultures, however medically advanced.
In another village, a man suggested a research
project to me. He proposed using actual and mock
sorcery bundles to test the sorcery theory of kuru and
volunteered himself to be the subject. His outline
protocol was not conceptually different from a placebo
controlled trial. I found his proposal to use an
experimental test very impressive, but, in addition to
ethical considerations, did not relish putting this before
the Neurosciences Board of the MRC.
Progress to date against our kuru research aims has
been reported elsewhere (Mead et al. 2003; Collinge
et al. 2006; Wadsworth et al. 2008a) and in this issue
(Alpers 2008; Brandner et al. 2008; Collinge et al.
2008; Mead et al. 2008; Wadsworth et al. 2008b;
Whitﬁeld et al. 2008). Little of this work would have
been possible without the generous collaboration of the
Fore communities who played a key role in helping us
understand a public health problem that was emerging
Figure 6. Old school building in Waisa.
Figure 7. New pre-school building.
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nity. Others from the UK assisted Jerome and his local
team of kuru reporters for varying intervals, including
Edward McKintosh, Eddy Lagan, Andrew Jackson,
Toby Bentley, Ian Calder, Francesco Scaravilli and
Adam Frosh. My distinguished neurological colleague
from Queen Square, Dafydd Thomas, also assisted
with assessment of patients. Many others were involved
and are recognized by authorship and acknowledge-
ment in the published papers. It is also vital to
acknowledge the continual support we have received
from the PNGIMR directors who have followed
Michael: John Reeder and now Peter Siba.
One unexpected ﬁnding from our work on genetic
susceptibility to kuru was the evidence for strong
worldwide balancing selection acting at the prion
protein gene locus during the evolution of modern
humans and consistent with previous kuru-like epi-
demics in human prehistory, when cannibalism was
thought to be widespread (Mead et al. 2003). It is also
instructive to reﬂect, as has been pointed out
previously, that use of tissue grafts and pituitary
hormones derived from human cadavers, which have
led to several hundred ‘iatrogenic’ cases of CJD in the
USA, Europe and Japan (Brown et al. 2006), could be
considered a modern western counterpart of canni-
balism. Even with this wider perspective, the word
cannibal remains highly pejorative and it would be
preferable if an alternative term could be found to
describe the ritual mortuary practices of the Fore.
One very special event to recollect here took place
at the annual PNG Medical Symposium that was held
in Goroka in 2005. While research communications
on the project have been made regularly at these
annual gatherings of the PMG medical profession, a
special session was held on kuru at the 2005 meeting.
Most importantly, this allowed several Fore members
of the research team to present their work and their
own personal experiences of kuru. The Fore presen-
tations were made with clarity and great dignity and
I think it is fair to say this had a profound impact at
the meeting.
A further important recollection for me was of the
visit of several Fore to the MRC Prion Unit and
the National Prion Clinic (which was then based at
St. Mary’s Hospital in London). This had been
arranged so that representatives on the Fore commu-
nities could see for themselves the research back in
London and meet with the researchers. The visit had a
major effect on my staff at the Unit and enduring
friendships were forged. The Fore were keen to learn
about vCJD and, importantly, it gave the opportunity
for a meeting with someone who had lost a child to
vCJD (ﬁgure 9). While I was aware of some striking
clinical similarities between vCJD and kuru, it was
fascinating as a clinician to hear discussions of the early
features of both kuru and vCJD being discussed by
relatives and the recognition during the discussions of
further similarities of the two diseases in their
prodrome and early clinical phases.
Kuru has taught us many lessons. The epidemic
probably arose from consumption of an individual
dying of sporadic CJD (a disease which appears to
occur as a rare spontaneous disease in all human
populations) by his or her kinship group, followed by
successive rounds of recycling within the community as
others developing or incubating the disease died
and were themselves consumed at mortuary feasts
(Alpers & Rail 1971). Recent strain typing of kuru
prion isolates supports this view (Wadsworth et al.
2008a). Undoubtedly, the BSE epizootic also occurred
owing to recycling of BSE prion-infected cattle into
cattle feed. Again the initiating source of infection
cannot be known with certainty, but there is little direct
evidence to support a sheep scrapie origin and it may
Figure 8. Michael Alpers and Fore greeting.
Figure 9. Visit of Fore representatives to National Prion
Clinic and their meeting with Mrs Gibbs.
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infection of cattle. While some cases of sporadic CJD
may relate to unidentiﬁed environmental exposure to
human or animal prions, most are thought to relate to
the rare spontaneous production of prions. There is no
reason to suppose such a process, which has been well
documented with yeast prions (Wickner et al. 2004),
would be unique to humans, and sporadic prion disease
probably occurs in all mammalian species, perhaps all
vertebrates. Intraspecies recycling (cannibalism) of
captive animals is therefore to be avoided as it risks
an epidemic from ampliﬁcation of naturally occurring
prions. Use of such material to feed another species
also carries some risk. While this will be mainly to
closely related species, transmission barriers cannot yet
be predicted for a new strain and may on occasion be
surprising. BSE was of course surprising in its
promiscuity and this may relate to selection of a
particularly thermodynamically stable strain by the
rendering (industrial cooking) process used to prepare
meat and bone meal (Collinge & Clarke 2007).
Discussions are now taking place in the European
Union on relaxation of the various control measures
in place affecting animal feed. While some relaxation
of especially precautionary measures may be appro-
priate, it is important that the lessons of kuru are not
forgotten again. Policy makers, understandably under
commercial pressures to relax controls, must be
clearly advised about the potential consequences of
recycling within the same or closely related species
and it is important for all those who have learned the
lessons of kuru to ensure this message is clearly
expressed and not lost with the passage of time and
turnover of policy makers. Although considerable
uncertainties remain about the extent of pre- and sub-
clinical infection of BSE-exposed human populations,
the number of clinical cases has been thankfully
relatively small (approx. 200). This suggests the
presence of an effective transmission barrier to BSE
prions in humans. Kuru reminds us, however, that
human prion disease epidemics, even in the absence
of such barriers, span over half a century (Collinge
et al.2 0 0 6 ). The effect of transmission barriers is to
extend both the mean and range of incubation
periods considerably. Of course, secondary (human-
to-human) transmission of vCJD prions by blood
transfusion has now been documented and appears a
worryingly efﬁcient route (Wroe et al.2 0 0 6 ); many
are also known to have been exposed to blood
products and surgical instruments potentially
contaminated with vCJD prions.
There is no known precedent for the widespread
high-level exposure of a large human population to a
novel animal prion strain as occurred with BSE.
Further, it is entirely possible that a new prion zoonosis,
should a return to cannibalistic recycling of animal
tissues be allowed, might have a signiﬁcantly less
effective barrier to transmission to humans than does
cattle BSE. The Fore have been extremely generous in
allowing us to delve further into their tragedy and learn
from their experience to better inform risks in Western
societies. It is to be hoped that these lessons of kuru are
now ﬁrmly learned by those responsible for public and
animal health worldwide.
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